GB0915523D0 - Cells and methods for obtaining them - Google Patents

Cells and methods for obtaining them

Info

Publication number
GB0915523D0
GB0915523D0 GBGB0915523.5A GB0915523A GB0915523D0 GB 0915523 D0 GB0915523 D0 GB 0915523D0 GB 0915523 A GB0915523 A GB 0915523A GB 0915523 D0 GB0915523 D0 GB 0915523D0
Authority
GB
United Kingdom
Prior art keywords
gene product
retinoic acid
cells
agonist
family member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0915523.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genome Research Ltd
Original Assignee
Genome Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genome Research Ltd filed Critical Genome Research Ltd
Priority to GBGB0915523.5A priority Critical patent/GB0915523D0/en
Publication of GB0915523D0 publication Critical patent/GB0915523D0/en
Priority to EP10754364A priority patent/EP2475774A1/en
Priority to PCT/GB2010/051493 priority patent/WO2011027180A1/en
Priority to US13/394,481 priority patent/US9512407B2/en
Priority to JP2012527396A priority patent/JP5944315B2/ja
Priority to CA2773291A priority patent/CA2773291A1/en
Priority to CN201080050341.XA priority patent/CN102822345B/zh
Priority to SG2012015343A priority patent/SG178613A1/en
Priority to SG10201405455UA priority patent/SG10201405455UA/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/602—Sox-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/603—Oct-3/4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/604—Klf-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/606—Transcription factors c-Myc
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB0915523.5A 2009-09-07 2009-09-07 Cells and methods for obtaining them Ceased GB0915523D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0915523.5A GB0915523D0 (en) 2009-09-07 2009-09-07 Cells and methods for obtaining them
EP10754364A EP2475774A1 (en) 2009-09-07 2010-09-07 Cells and methods for obtaining them
PCT/GB2010/051493 WO2011027180A1 (en) 2009-09-07 2010-09-07 Cells and methods for obtaining them
US13/394,481 US9512407B2 (en) 2009-09-07 2010-09-07 Cells and methods for obtaining them
JP2012527396A JP5944315B2 (ja) 2009-09-07 2010-09-07 細胞およびそれらを得るための方法
CA2773291A CA2773291A1 (en) 2009-09-07 2010-09-07 Induced pluripotent stem cells and methods for obtaining them
CN201080050341.XA CN102822345B (zh) 2009-09-07 2010-09-07 细胞及其获得方法
SG2012015343A SG178613A1 (en) 2009-09-07 2010-09-07 Cells and methods for obtaining them
SG10201405455UA SG10201405455UA (en) 2009-09-07 2010-09-07 Cells and methods for obtaining them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0915523.5A GB0915523D0 (en) 2009-09-07 2009-09-07 Cells and methods for obtaining them

Publications (1)

Publication Number Publication Date
GB0915523D0 true GB0915523D0 (en) 2009-10-07

Family

ID=41203246

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0915523.5A Ceased GB0915523D0 (en) 2009-09-07 2009-09-07 Cells and methods for obtaining them

Country Status (8)

Country Link
US (1) US9512407B2 (enExample)
EP (1) EP2475774A1 (enExample)
JP (1) JP5944315B2 (enExample)
CN (1) CN102822345B (enExample)
CA (1) CA2773291A1 (enExample)
GB (1) GB0915523D0 (enExample)
SG (2) SG10201405455UA (enExample)
WO (1) WO2011027180A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5880868B2 (ja) 2009-09-30 2016-03-09 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 核内受容体及びその変異体、並びに細胞の再プログラミングにおけるその使用
EP2627342B1 (en) * 2010-10-14 2016-08-24 University Of Central Florida Research Foundation, Inc. Cardiac induced pluripotent stem cells and methods of use in repair and regeneration of myocardium
GB2496375A (en) 2011-10-28 2013-05-15 Kymab Ltd A non-human assay vertebrate comprising human antibody loci and human epitope knock-in, and uses thereof
GB201122047D0 (en) 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals
US10745668B2 (en) * 2013-09-20 2020-08-18 Lonza Ltd Methods for nuclear reprogramming of cells
US10023879B2 (en) * 2014-06-04 2018-07-17 Fate Therapeutics, Inc. Minimal volume reprogramming of mononuclear cells
US20190282624A1 (en) * 2015-11-30 2019-09-19 Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. Improved methods for reprograming non-pluripotent cells into pluripotent stem cells
CN109750000A (zh) * 2017-11-06 2019-05-14 内蒙古赛科星家畜种业与繁育生物技术研究院有限公司 利用XistTale抑制性转录因子R6制备新型动物细胞系R6-MEFs方法及用途
CN109913494A (zh) * 2019-02-12 2019-06-21 北京呈诺医学科技有限公司 一种新的ips细胞的诱导方法
CN110218741B (zh) * 2019-05-31 2020-12-25 华中农业大学 采用串联sgRNA同步激活多个猪内源性干细胞因子转录活性的方法
CN110592014A (zh) * 2019-08-14 2019-12-20 广东美赛尔细胞生物科技有限公司 一种在nk细胞治疗中免辐照体外体内持续去除饲养细胞的方法
CN114703227B (zh) * 2022-01-27 2023-11-10 中国科学院生态环境研究中心 基于MCF-7细胞系构建的RARα效应物体外筛选方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0411323A3 (en) 1989-06-30 1991-08-21 Institut National De La Sante Et De La Recherche Medicale (Inserm) Human and mouse retinoic acid receptors and genes encoding for them
US5663303A (en) 1991-11-04 1997-09-02 Institut National De La Sante Et De La Recherche Medicale Antibodies specific for retinoic acid receptor-γ
CN100374416C (zh) 2000-04-28 2008-03-12 霍夫曼-拉罗奇有限公司 对(磺酰基)芳基和杂芳基类化合物
US20070224615A1 (en) * 2003-07-09 2007-09-27 Invitrogen Corporation Methods for assaying protein-protein interactions
US7476673B2 (en) 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
WO2005080973A1 (en) 2004-02-13 2005-09-01 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human nuclear receptor nr5a1 (nr5a1)
WO2005082344A1 (en) 2004-02-24 2005-09-09 Smithkline Beecham Corporation Lhr1 activators as medicaments
CA2617611A1 (en) 2005-08-01 2007-02-08 Nupotential, Llc Production of reprogrammed cells with restored potential
EP4223769A3 (en) 2005-12-13 2023-11-01 Kyoto University Nuclear reprogramming factor
WO2008064136A2 (en) 2006-11-17 2008-05-29 Acadia Pharmaceuticals Inc. Compounds with activity at retinoic acid receptors
AU2008326800A1 (en) 2007-11-16 2009-05-28 Baylor College Of Medicine Phospholipid compositions and uses thereof
US9683232B2 (en) 2007-12-10 2017-06-20 Kyoto University Efficient method for nuclear reprogramming
AU2008286249B2 (en) 2007-12-10 2013-10-10 Kyoto University Efficient method for nuclear reprogramming
CN101250502A (zh) * 2008-04-01 2008-08-27 中国科学院上海生命科学研究院 一种诱导的多潜能干细胞的制备方法
JP5880868B2 (ja) * 2009-09-30 2016-03-09 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 核内受容体及びその変異体、並びに細胞の再プログラミングにおけるその使用

Also Published As

Publication number Publication date
EP2475774A1 (en) 2012-07-18
JP5944315B2 (ja) 2016-07-05
CN102822345A (zh) 2012-12-12
CN102822345B (zh) 2016-06-08
SG10201405455UA (en) 2014-10-30
WO2011027180A1 (en) 2011-03-10
SG178613A1 (en) 2012-04-27
US9512407B2 (en) 2016-12-06
CA2773291A1 (en) 2011-03-10
JP2013503622A (ja) 2013-02-04
US20120315703A1 (en) 2012-12-13

Similar Documents

Publication Publication Date Title
GB0915523D0 (en) Cells and methods for obtaining them
ATE523585T1 (de) Differenzierung menschlicher embryonaler stammzellen
MX2010000746A (es) Diferenciacion de celulas madre embrionarias humanas.
NZ603996A (en) Cells or cell lines that stably express a bitter taste receptor and methods of making them
EP2564541A4 (en) Apparatus and method for feeding back data receiving status
MX2012003132A (es) Metodo de retroalimentacion de informacion y equipo de usuario.
MX2013008772A (es) Dispositivo, sistema y metodo para la alimentacion de ganado.
MX2013015131A (es) Dispositivo de control de comunicacion, metodo y programa de control de comunicacion.
IN2014MN00891A (enExample)
EP2512129A4 (en) Digital broadcast receiving apparatus, digital broadcast receiving method and computer program
EP2577923A4 (en) Apparatus, method and computer program product for selecting beam group and subset of beams in communication system
WO2012061770A3 (en) Mobility for multipoint operations
SG10201900323SA (en) Method for inducing t cells for cell-based immunotherapy from pluripotent stem cells
EP4477668A3 (en) Heterodimeric antibody fc-containing proteins and methods for production thereof
WO2011130402A3 (en) Hepatocyte production by forward programming
IN2014CN03749A (enExample)
MY185753A (en) Coding apparatus and decoding apparatus with bandwidth extension
MY170720A (en) Antibody formulations
MX341101B (es) Aparato transceptor de señales y metodo para transmitir y recibr señales.
GB201020028D0 (en) Transport prioritzation based on message type
MX353322B (es) Modulacion antisentido de la expresion de gcgr.
SG195190A1 (en) Dispersion and detachment of cell aggregates
IN2012DN02073A (enExample)
IN2014KN00922A (enExample)
EP2555055A4 (en) SUPPORT CORE MATERIAL FOR ELECTROPHOTOGRAPHIC DEVELOPER, METHOD FOR PRODUCING THE SAME, SUPPORT FOR ELECTROPHOTOGRAPHIC DEVELOPER, AND ELECTROPHOTOGRAPHIC DEVELOPER

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)